Rise in illegal e-cigarettes seized in UK

Events by 2FIRSTS.ai
Jun.26.2023
Rise in illegal e-cigarettes seized in UK
The UK has seized millions of illegal e-cigarettes with high nicotine concentrations and metal content. Concerns have risen over youth vape use.

According to a report from The Guardian, data from 125 local governments in the UK shows that the country's trade standards department has seized millions of illegal e-cigarettes since the beginning of 2020.

 

In the past three years, trade standard departments across the country have confiscated over 2.5 million illegal e-cigarettes. In the city of Hounslow, located near Heathrow Airport (a major entry point for illegal trade), law enforcement officials have already seized over 1.35 million e-cigarettes.

 

These illegal e-cigarettes do not comply with UK e-cigarette regulatory laws and may have higher levels of nicotine concentration, prohibited ingredients, or super capacity e-liquid. Laboratory research has also found that illegal e-cigarettes may contain high levels of heavy metal components.

 

According to Kate Pike, director of the British Franchise Association, these figures are just the "tip of the iceberg".

 

There are numerous illegal products in the market that young people have access to. We don't want children or adults to become addicted to these types of products.

 

At the beginning of this month, leaders of the UK National Health Service (NHS) expressed concern over the number of children being admitted to hospital for treatment due to using e-cigarettes.

 

According to the NHS, in 2022, 40 children and young people in England were hospitalized due to "e-cigarette-related illnesses," compared to only 11 two years ago.

 

Pediatricians have also warned that "teen use of e-cigarettes is becoming a rapidly spreading epidemic among children," and are calling on the government to ban disposable e-cigarettes.

 

A spokesperson from the UK Department of Health and Social Care informed The Guardian:

 

Selling nicotine e-cigarettes to children is illegal. We are concerned about the increasing use of e-cigarettes among young people, especially because the long-term potential risks are still unclear.

 

Reference: [1] The seizure of over 2.5 million illegal vaping products in the past three years represents only a small portion of the problem.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
Carlos Cabrera, founder of CabLab Law & Advocacy, contributes this article to 2Firsts, arguing that the EU’s evolving approach to novel tobacco regulation may unintentionally reinforce cigarette use by narrowing alternatives. He warns companies to watch signals on flavours, labelling, traceability, nicotine pouch rules and digital marketing, while grounding business decisions in realistic timelines, compliance planning and continuous monitoring.
Apr.22
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
The Tasmanian government has tabled the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026 in Parliament, proposing new offences, higher penalties and stronger enforcement powers to crack down on illicit tobacco and vaping products.
Mar.25 by 2FIRSTS.ai
Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick.com said it will continue its collaboration with zone for a second year at the April 19 NASCAR race in Kansas City, appearing on Richard Childress Racing’s No. 8 Chevrolet driven by Kyle Busch. The 2026 race-weekend campaign for verified adult nicotine consumers aged 21 and older includes the exclusive launch of zone Cranberry and a limited-edition five-flavor mix pack selected by Busch.
Apr.16 by 2FIRSTS.ai
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai